Key statistics
On Monday, Akebia Therapeutics Inc (AKBA:NAQ) closed at 1.26, 10.53% above the 52 week low of 1.14 set on Feb 20, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.27 |
|---|---|
| High | 1.30 |
| Low | 1.24 |
| Bid | 1.23 |
| Offer | 1.24 |
| Previous close | 1.31 |
| Average volume | 3.42m |
|---|---|
| Shares outstanding | 267.88m |
| Free float | 248.34m |
| P/E (TTM) | -- |
| Market cap | 337.53m USD |
| EPS (TTM) | -0.0179 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Events & Activity
- AKBA:NAQ reported earnings of -0.05 for the period of the year 2025Q4.
- AKBA:NAQ trading volume exceeds daily average by +63.60%
- AKBA:NAQ price moved over +21.07% to 1.47
- AKBA:NAQ price falls below 15-day moving average to 1.27 at 14:30 GMT
- AKBA:NAQ price rises above 50-day moving average to 1.47 at 14:30 GMT
- AKBA:NAQ price falls below 15-day moving average to 1.30 at 14:30 GMT
